158 related articles for article (PubMed ID: 28971493)
1. Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Ureshino H; Ando T; Kizuka H; Kusaba K; Sano H; Nishioka A; Itamura H; Shindo T; Kubota Y; Kojima K; Kimura S
Hematol Oncol; 2018 Feb; 36(1):324-327. PubMed ID: 28971493
[TBL] [Abstract][Full Text] [Related]
2. Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated.
Abboud R; Keller J; Slade M; DiPersio JF; Westervelt P; Rettig MP; Meier S; Fehniger TA; Abboud CN; Uy GL; Vij R; Trinkaus KM; Schroeder MA; Romee R
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1851-1860. PubMed ID: 27318038
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Nishimoto M; Hirose A; Koh H; Nakamae M; Nanno S; Okamura H; Nakane T; Nakashima Y; Hino M; Nakamae H
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2061-2069. PubMed ID: 31195139
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma.
Caimi PF; Pacheco Sanchez G; Sharma A; Otegbeye F; Ahmed N; Rojas P; Patel S; Kleinsorge Block S; Schiavone J; Zamborsky K; Boughan K; Hillian A; Reese-Koc J; Maschan M; Dropulic B; Sekaly RP; de Lima M
Front Immunol; 2021; 12():745320. PubMed ID: 34712233
[TBL] [Abstract][Full Text] [Related]
5. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.
Le RQ; Li L; Yuan W; Shord SS; Nie L; Habtemariam BA; Przepiorka D; Farrell AT; Pazdur R
Oncologist; 2018 Aug; 23(8):943-947. PubMed ID: 29622697
[TBL] [Abstract][Full Text] [Related]
6. The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantation.
De Togni E; Wan F; Slade M; Plach K; Abboud R
Leuk Lymphoma; 2022 Dec; 63(12):2975-2981. PubMed ID: 35848998
[TBL] [Abstract][Full Text] [Related]
7. Cervical Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Inoue Y; Fujino T; Chinen S; Niiyama-Uchibori Y; Ide D; Kawata M; Hashimoto K; Takimoto-Shimomura T; Nakayama A; Tsukamoto T; Mizutani S; Shimura Y; Hirano S; Kuroda J
Cureus; 2023 May; 15(5):e38905. PubMed ID: 37303362
[TBL] [Abstract][Full Text] [Related]
8. Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Imus PH; Blackford AL; Bettinotti M; Luznik L; Fuchs EJ; Huff CA; Gladstone DE; Ambinder RF; Borrello IM; Fuchs RJ; Swinnen LJ; Wagner-Johnston N; Gocke CB; Ali SA; Bolaños-Meade FJ; Jones RJ; Dezern AE
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2431-2437. PubMed ID: 31394272
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome.
Raj RV; Hamadani M; Szabo A; Pasquini MC; Shah NN; Drobyski WR; Shaw BE; Saber W; Rizzo JD; Jerkins J; Fenske TS; D'Souza A; Dhakal B; Zhang C; Konings S; Hari PN; Chhabra S
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1664-1670. PubMed ID: 29680516
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation.
Jayakumar I; Uppuluri R; Lakshmanan C; Kumar Gowdhaman A; Vellaichamy Swaminathan V; Raj R
Pediatr Transplant; 2021 Aug; 25(5):e13964. PubMed ID: 33370509
[TBL] [Abstract][Full Text] [Related]
11. Cytokine release syndrome: Who is at risk and how to treat.
Frey N
Best Pract Res Clin Haematol; 2017 Dec; 30(4):336-340. PubMed ID: 29156206
[TBL] [Abstract][Full Text] [Related]
12. Management of cytokine release syndrome related to CAR-T cell therapy.
Chen H; Wang F; Zhang P; Zhang Y; Chen Y; Fan X; Cao X; Liu J; Yang Y; Wang B; Lei B; Gu L; Bai J; Wei L; Zhang R; Zhuang Q; Zhang W; Zhao W; He A
Front Med; 2019 Oct; 13(5):610-617. PubMed ID: 31571160
[TBL] [Abstract][Full Text] [Related]
13. Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia.
Frey NV; Porter DL
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):567-572. PubMed ID: 27913530
[TBL] [Abstract][Full Text] [Related]
14. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.
Teachey DT; Lacey SF; Shaw PA; Melenhorst JJ; Maude SL; Frey N; Pequignot E; Gonzalez VE; Chen F; Finklestein J; Barrett DM; Weiss SL; Fitzgerald JC; Berg RA; Aplenc R; Callahan C; Rheingold SR; Zheng Z; Rose-John S; White JC; Nazimuddin F; Wertheim G; Levine BL; June CH; Porter DL; Grupp SA
Cancer Discov; 2016 Jun; 6(6):664-79. PubMed ID: 27076371
[TBL] [Abstract][Full Text] [Related]
15. Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis.
Abboud R; Wan F; Mariotti J; Arango M; Castagna L; Romee R; Hamadani M; Chhabra S
Bone Marrow Transplant; 2021 Nov; 56(11):2763-2770. PubMed ID: 34262142
[TBL] [Abstract][Full Text] [Related]
16. Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.
Abid MB; Hamadani M; Szabo A; Hari PN; Graham MB; Frank MO; Collier WS; Abedin S; Jerkins JH; Pasquini MC; Runaas L; Shah NN; Chhabra S
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1670-1678. PubMed ID: 32562858
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).
Alvi RM; Frigault MJ; Fradley MG; Jain MD; Mahmood SS; Awadalla M; Lee DH; Zlotoff DA; Zhang L; Drobni ZD; Hassan MZO; Bassily E; Rhea I; Ismail-Khan R; Mulligan CP; Banerji D; Lazaryan A; Shah BD; Rokicki A; Raje N; Chavez JC; Abramson J; Locke FL; Neilan TG
J Am Coll Cardiol; 2019 Dec; 74(25):3099-3108. PubMed ID: 31856966
[TBL] [Abstract][Full Text] [Related]
18. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
19. Fatal Severe Cytokine Release Syndrome Post-haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide in an Infant With Severe Combined Immunodeficiency and Disseminated Bacille Calmette-Guérin Infection.
Arora S; Upasana K; Thakkar D; Yadav A; Rastogi N; Yadav SP
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e773-e774. PubMed ID: 37494614
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies.
Kauer J; Hörner S; Osburg L; Müller S; Märklin M; Heitmann JS; Zekri L; Rammensee HG; Salih HR; Jung G
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32474413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
